Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies

Nick Petrić Howe, Maren Hunsberger

Published Aug 21, 2026

Episode site

Guests:

Nick Petrić Howecontributor
Maren Hunsbergercontributor

No recording yet

Episode Description

Nature staff discuss how a newly approved orexin-targeting narcolepsy drug could enable therapies for other neurological conditions, and examine human brain organoids that have remained viable for more than five years. The episode connects sleep medicine, therapeutic neuroscience, and long-term models of human brain development.

Topics Discussed

narcolepsyorexinbrain organoidsneurological therapeutics

More Episodes

How to Improve Motivation & Overcome Procrastination | Dr. Masud Husain

Aug 24, 2026

BI 244 Marco Facchin: Philosophy and Science of Biological Brains

1h 30mAug 19, 2026

Neuroscience of Emotions & Tools for Improving Emotion Regulation | Dr. Ralph Adolphs

Aug 17, 2026

Using AI to Increase Your Intelligence & Enrich Humanity | Dr. Fei-Fei Li

2h 6mAug 10, 2026

Briefing Chat: Is DNA repair the secret to a long life?

Aug 7, 2026